How does IDXX's Q1 2025 forecast compare to past trends?

IDEXX Laboratories' Q1 2025 forecast shows a significant increase in estimated EPS and revenue compared to the previous quarter and year, indicating a strong performance and potential growth.

1. **Comparison to Q4 2024**:
- Estimated EPS: The EPS for Q1 2025 is $2.93, which is higher than the $2.4 reported for Q4 2024.
- Estimated Revenue: The estimated revenue for Q1 2025 is $1.01 billion, significantly higher than the $936.68 million reported for Q4 2024.
2. **Comparison to Q4 2023**:
- Estimated EPS: The EPS for Q1 2025 is also higher than the $2.12 reported for Q4 2023.
- Estimated Revenue: The estimated revenue for Q1 2025 is substantially higher than the figures reported for Q4 2023, which were not provided.
3. **Comparison to Q4 2022**:
- Estimated EPS: The EPS for Q1 2025 shows a notable increase from the $1.94 reported for Q4 2022.
- Estimated Revenue: The estimated revenue for Q1 2025 is significantly higher than the figures reported for Q4 2022, which were not provided.

In summary, IDEXX Laboratories is expected to have a strong performance in Q1 2025, with significant increases in both EPS and revenue compared to the immediate previous quarter and year, suggesting a positive outlook for the company.